Assessment of the Genetic Spectrum of Uncombable Hair Syndrome in a Cohort of 107 Individuals.


Journal

JAMA dermatology
ISSN: 2168-6084
Titre abrégé: JAMA Dermatol
Pays: United States
ID NLM: 101589530

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 1 9 2022
medline: 19 11 2022
entrez: 31 8 2022
Statut: ppublish

Résumé

Uncombable hair syndrome (UHS) is a rare hair shaft anomaly that manifests during infancy and is characterized by dry, frizzy, and wiry hair that cannot be combed flat. Only about 100 known cases have been reported so far. To elucidate the genetic spectrum of UHS. This cohort study includes 107 unrelated index patients with a suspected diagnosis of UHS and family members who were recruited worldwide from January 2013 to December 2021. Participants of all ages, races, and ethnicities were recruited at referral centers or were enrolled on their own initiative following personal contact with the authors. Genetic analyses were conducted in Germany from January 2014 to December 2021. Clinical photographs, Sanger or whole-exome sequencing and array-based genotyping of DNA extracted from blood or saliva samples, and 3-dimensional protein modeling. Descriptive statistics, such as frequency counts, were used to describe the distribution of identified pathogenic variants and genotypes. The genetic characteristics of patients with UHS were established in 80 of 107 (74.8%) index patients (82 [76.6%] female) who carried biallelic pathogenic variants in PADI3, TGM3, or TCHH (ie, genes that encode functionally related hair shaft proteins). Molecular genetic findings from 11 of these 80 individuals were previously published. In 76 (71.0%) individuals, the UHS phenotype were associated with pathogenic variants in PADI3. The 2 most commonly observed PADI3 variants account for 73 (48.0%) and 57 (37.5%) of the 152 variant PADI3 alleles in total, respectively. Two individuals carried pathogenic variants in TGM3, and 2 others carried pathogenic variants in TCHH. Haplotype analyses suggested a founder effect for the 4 most commonly observed pathogenic variants in the PADI3 gene. This cohort study extends and gives an overview of the genetic variant spectrum of UHS based on molecular genetic analyses of the largest worldwide collective of affected individuals, to our knowledge. Formerly, a diagnosis of UHS could only be made by physical examination of the patient and confirmed by microscopical examination of the hair shaft. The discovery of pathogenic variants in PADI3, TCHH, and TGM3 may open a new avenue for clinicians and affected individuals by introducing molecular diagnostics for UHS.

Identifiants

pubmed: 36044230
pii: 2795483
doi: 10.1001/jamadermatol.2022.2319
pmc: PMC9434486
doi:

Substances chimiques

TGM3 protein, human EC 2.3.2.13
Transglutaminases EC 2.3.2.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1245-1253

Auteurs

F Buket Basmanav (FB)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Nicole Cesarato (N)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Sheetal Kumar (S)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Oleg Borisov (O)

Institute for Genomic Statistics and Bioinformatics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Pavlos Kokordelis (P)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Damian J Ralser (DJ)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Maria Wehner (M)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Daisy Axt (D)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Xing Xiong (X)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Holger Thiele (H)

Cologne Center for Genomics, University of Cologne, Cologne, Germany.

Vadim Dolgin (V)

Genetics Institute at Soroka University Medical Center, Beer-Sheva, Israel.
Morris Kahn Laboratory of Human Genetics, National Center for Rare Diseases at the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Yasmina Gossmann (Y)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Nadine Fricker (N)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Malin Katharina Dewenter (MK)

Institute of Human Genetics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.

Karsten Weller (K)

Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Mohnish Suri (M)

Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, England, United Kingdom.

Herbert Reichenbach (H)

MVZ Mitteldeutscher Praxisverbund Humangenetik, Praxis Leipzig, Leipzig, Germany.

Vinzenz Oji (V)

Department of Dermatology, University of Münster, Münster, Germany.

Marie-Claude Addor (MC)

Department of Woman-Mother-Child, University Hospital Center CHUV CH 1011, Lausanne, Switzerland.

Karla Ramirez (K)

Neurología Pediátrica, Division de Pediatría, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

Helen Stewart (H)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, England, United Kingdom.

Natalie Garcia Bartels (N)

Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Lisa Weibel (L)

Pediatric Dermatology Department, University Children's Hospital Zurich, University Hospital Zurich, Zurich, Switzerland.
Dermatology Department, University Hospital Zurich, Zurich, Switzerland.

Nicola Wagner (N)

Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.

Susannah George (S)

Dermatology Department, Brighton General Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, England, United Kingdom.

Arzu Kilic (A)

Department of Dermatology, Faculty of Medicine, Balıkesir University, Balıkesir, Turkey.

Iliana Tantcheva-Poor (I)

Department of Dermatology and Venereology, University Hospital of Cologne, Cologne, Germany.

Alison Stewart (A)

Sheffield Clinical Genetics Service, Sheffield Children's Hospital, South Yorkshire, England, United Kingdom.

Nicola Dikow (N)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Bettina Blaumeiser (B)

Department of Medical Genetics, University of Antwerp, Antwerp, Belgium.

Márta Medvecz (M)

Department of Dermatology, Venereology, and Dermatooncology, Semmelweis University, Budapest, Hungary.

Ulrike Blume-Peytavi (U)

Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Paul Farrant (P)

Dermatology Department, Brighton General Hospital, University Hospitals Sussex NHS Foundation Trust, Brighton, England, United Kingdom.

Ramon Grimalt (R)

Universitat Internacional de Catalunya, Barcelona, Spain.

Sara Bertok (S)

Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia.

Lisa Bradley (L)

Department of Clinical Genetics, Children's Health Ireland (CHI) at Crumlin, Dublin, Ireland.

Marina Eskin-Schwartz (M)

Genetics Institute at Soroka University Medical Center, Beer-Sheva, Israel.

Ohad Samuel Birk (OS)

Genetics Institute at Soroka University Medical Center, Beer-Sheva, Israel.

Anette Bygum (A)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Clinical Institute, University of Southern Denmark, Odense, Denmark.

Michel Simon (M)

Toulouse Institute for Infectious and Inflammatory diseases, Toulouse University, Toulouse, France.
CNRS, Inserm, Paul Sabatier Toulouse III University, Toulouse, France.

Peter Krawitz (P)

Institute for Genomic Statistics and Bioinformatics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Christine Fischer (C)

Institute of Human Genetics, Heidelberg University, Heidelberg, Germany.

Henning Hamm (H)

Department of Dermatology, Venereology, and Allergology, University Hospital Würzburg, Würzburg, Germany.

Günter Fritz (G)

Department of Cellular Microbiology, University of Hohenheim, Stuttgart, Germany.

Regina C Betz (RC)

Institute of Human Genetics, Medical Faculty & University Hospital Bonn, University of Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH